Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -31.93%747.65M | -23.16%621.67M | -6.04%489.14M | 13.33%252.2M | 40.70%1.1B | 49.27%809.02M | 58.69%520.6M | 67.79%222.54M | 76.54%780.63M | 77.25%541.98M |
| Operating income | -31.93%747.65M | -6.04%489.14M | 40.70%1.1B | 58.69%520.6M | 76.54%780.63M | |||||
| Cost of sales | -13.54%-358.67M | ---- | 5.28%-136.1M | ---- | -52.87%-315.9M | ---- | -84.08%-143.7M | ---- | -188.76%-206.64M | ---- |
| Operating expenses | -13.54%-358.67M | 5.28%-136.1M | -52.87%-315.9M | -84.08%-143.7M | -188.76%-206.64M | |||||
| Gross profit | -50.29%388.98M | -6.33%353.04M | 36.32%782.43M | 50.76%376.91M | 54.87%573.99M | |||||
| Selling expenses | 46.58%-324.09M | ---- | -0.35%-277.45M | ---- | -37.57%-606.71M | ---- | -40.08%-276.48M | ---- | -116.23%-441.02M | ---- |
| Administrative expenses | 4.77%-77.49M | ---- | -8.16%-34.73M | ---- | -19.13%-81.38M | ---- | -3.22%-32.11M | ---- | -9.14%-68.31M | ---- |
| Research and development expenses | -8.02%-85.68M | ---- | 22.65%-35.63M | ---- | 23.66%-79.31M | ---- | 7.82%-46.06M | ---- | 31.28%-103.89M | ---- |
| Impairment and provision | -145.30%-3.63M | ---- | -94.61%509K | ---- | 169.72%8.01M | ---- | 1,868.96%9.45M | ---- | -1,823.12%-11.48M | ---- |
| -Other impairment is provision | -145.30%-3.63M | ---- | -94.61%509K | ---- | 169.72%8.01M | ---- | 1,868.96%9.45M | ---- | -1,823.12%-11.48M | ---- |
| Special items of operating profit | -38.45%11.21M | ---- | 121.88%3.43M | ---- | 3.18%18.22M | ---- | -88.46%1.55M | ---- | 104.92%17.65M | ---- |
| Operating profit | -319.84%-90.69M | -72.40%9.18M | 224.79%41.25M | 328.17%33.26M | 15.40%-33.06M | |||||
| Financing income | -33.61%2.25M | ---- | -42.71%1.25M | ---- | 13.75%3.38M | ---- | 70.74%2.18M | ---- | 31.30%2.97M | ---- |
| Financing cost | -20.67%-11.92M | ---- | -64.03%-6.37M | ---- | -90.92%-9.88M | ---- | -71.65%-3.88M | ---- | 21.61%-5.18M | ---- |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 62.39%-2.5M | ---- |
| Earning before tax | -388.77%-100.37M | -87.13%4.06M | 192.06%34.76M | 308.15%31.56M | 24.56%-37.76M | |||||
| Tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1K | ---- |
| After-tax profit from continuing operations | -388.77%-100.37M | -87.13%4.06M | 192.05%34.76M | 308.13%31.56M | 24.56%-37.76M | |||||
| Earning after tax | -388.77%-100.37M | -109.52%-3.37M | -87.13%4.06M | -71.76%2.09M | 192.05%34.76M | 209.30%35.4M | 308.13%31.56M | 145.24%7.41M | 24.56%-37.76M | 22.28%-32.39M |
| Profit attributable to shareholders | -388.77%-100.37M | -109.52%-3.37M | -87.13%4.06M | -71.76%2.09M | 192.05%34.76M | 209.30%35.4M | 308.13%31.56M | 145.24%7.41M | 24.36%-37.76M | 20.10%-32.39M |
| Basic earnings per share | -380.00%-0.14 | -75.00%0.01 | 200.00%0.05 | 300.00%0.04 | 37.50%-0.05 | |||||
| Diluted earnings per share | -380.00%-0.14 | -75.00%0.01 | 200.00%0.05 | 300.00%0.04 | 37.50%-0.05 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | PwC | -- | -- | -- | PwC | -- | -- | -- | PwC | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.